Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

S-Equol in Alzheimer's Disease 2 Trial (SEAD2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03101085
Recruitment Status : Completed
First Posted : April 4, 2017
Last Update Posted : August 13, 2021
Ausio Pharmaceuticals, LLC
Information provided by (Responsible Party):
Russell Swerdlow, University of Kansas Medical Center

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : March 1, 2021
Actual Study Completion Date : March 1, 2021